Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9842884rdf:typepubmed:Citationlld:pubmed
pubmed-article:9842884lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:9842884lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:9842884lifeskim:mentionsumls-concept:C1517495lld:lifeskim
pubmed-article:9842884lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:9842884lifeskim:mentionsumls-concept:C1136169lld:lifeskim
pubmed-article:9842884lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:9842884lifeskim:mentionsumls-concept:C0205171lld:lifeskim
pubmed-article:9842884lifeskim:mentionsumls-concept:C0205232lld:lifeskim
pubmed-article:9842884pubmed:issue11lld:pubmed
pubmed-article:9842884pubmed:dateCreated1998-12-17lld:pubmed
pubmed-article:9842884pubmed:abstractTextIn systemic lupus erythematosus, the nucleosome assumes a central role in the autoimmune response to self antigens. To gain insight into the etiology and pathogenesis of anti-nucleosome antibodies (Ab), we analyzed a panel of six IgG-secreting hybridomas derived from a single young MRL +/+ mouse at the onset of the autoimmune response. All monoclonal antibodies (mAb) bound exclusively the native nucleosome, and represented five different clonotypes that recognized diverse nucleosomal epitopes, typical of a polyclonal response. The VH-complementarity-determining region (CDR)3 regions exhibited unique stretches of charged amino acids with different polarity that may be important for the interaction with the nucleosome. These early anti-nucleosome mAb displayed striking structural differences with not only anti-DNA, but also with anti-nucleosome Ab, that appear later in disease. Two of the mAb deposited in kidney glomeruli after in vivo administration to RAG-1-deficient mice, suggesting that diverse B cell clones, possibly selected by the nucleosome itself, may play a role in the initiation of kidney damage.lld:pubmed
pubmed-article:9842884pubmed:languageenglld:pubmed
pubmed-article:9842884pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9842884pubmed:citationSubsetIMlld:pubmed
pubmed-article:9842884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9842884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9842884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9842884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9842884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9842884pubmed:statusMEDLINElld:pubmed
pubmed-article:9842884pubmed:monthNovlld:pubmed
pubmed-article:9842884pubmed:issn0014-2980lld:pubmed
pubmed-article:9842884pubmed:authorpubmed-author:GilbertDDlld:pubmed
pubmed-article:9842884pubmed:authorpubmed-author:CAMPH MHMlld:pubmed
pubmed-article:9842884pubmed:authorpubmed-author:EilatDDlld:pubmed
pubmed-article:9842884pubmed:authorpubmed-author:AmouraZZlld:pubmed
pubmed-article:9842884pubmed:authorpubmed-author:ChabraDDlld:pubmed
pubmed-article:9842884pubmed:authorpubmed-author:KoutouzovSSlld:pubmed
pubmed-article:9842884pubmed:authorpubmed-author:JovelinFFlld:pubmed
pubmed-article:9842884pubmed:authorpubmed-author:MostoslavskyG...lld:pubmed
pubmed-article:9842884pubmed:issnTypePrintlld:pubmed
pubmed-article:9842884pubmed:volume28lld:pubmed
pubmed-article:9842884pubmed:ownerNLMlld:pubmed
pubmed-article:9842884pubmed:authorsCompleteYlld:pubmed
pubmed-article:9842884pubmed:pagination3411-22lld:pubmed
pubmed-article:9842884pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:meshHeadingpubmed-meshheading:9842884-...lld:pubmed
pubmed-article:9842884pubmed:year1998lld:pubmed
pubmed-article:9842884pubmed:articleTitleEarly anti-nucleosome autoantibodies from a single MRL+/+ mouse: fine specificity, V gene structure and pathogenicity.lld:pubmed
pubmed-article:9842884pubmed:affiliationGroupe de Recherche en Immunopathologie (Institut de Recherche Multidisciplinaire sur les Peptides, IFR 23), Faculté mixte de Médecine et de Pharmacie, Centre Hospitalier Charles Nicolle, Rouen, France.lld:pubmed
pubmed-article:9842884pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9842884pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9842884lld:pubmed